Related Experiment Video
Updated: Sep 26, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
What are the best first-line antihypertensives: answers and more questions from the ALLHAT study
1Department of Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar. amaramin@yahoo.com
Insights
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) found that common diuretics are as effective as newer drugs for treating hypertension. This large study guides first-line treatment recommendations for high blood pressure.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Hypertension management is crucial for preventing cardiovascular events.
- Identifying optimal first-line antihypertensive therapy remains a key clinical challenge.
- Previous research suggested newer agents might offer advantages over older ones.
Purpose of the Study:
- To compare the cardiovascular effects of newer antihypertensive drug classes against a diuretic.
- To determine the recommended first-line agent for hypertension treatment.
- To analyze the clinical significance and implications of the ALLHAT findings.
Main Methods:
- The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was the largest antihypertensive therapy trial.
- Compared cardiovascular outcomes of diuretics versus three newer antihypertensive classes.
- Assessed efficacy and safety profiles of different treatment strategies.
Main Results:
- Diuretics demonstrated comparable efficacy to newer agents in preventing major cardiovascular outcomes.
- No significant differences in major cardiovascular events were observed across the compared drug classes.
- The study provided robust evidence on the effectiveness of established therapies.
Conclusions:
- Diuretics are a cost-effective and effective first-line treatment for hypertension.
- The ALLHAT findings challenge previous assumptions about the superiority of newer antihypertensive drugs.
- Further research is needed to address emerging questions and refine hypertension management strategies.
Abstract:
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is considered the largest trial of antihypertensive therapy conducted to date. It compared the cardiovascular effects of three more recently developed classes of antihypertensive agents to those of a diuretic in an attempt to identify which of these drugs should be the recommended first-line agent for the treatment of hypertension. In this report the paper is discussed with the significance and the clinical implications of the results contrasted with existing evidence in hypertension research. Additionally, further questions raised by the ALLHAT study are explored with ongoing studies, and future directions with which to answer these emerging new questions are outlined.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Angiotensin II Receptor Blockers